Recent Progress in Vaccine Development against Leishmania Species Infections

Recent Progress in Vaccine Development against Leishmania Species Infections

The understanding of the immunobiology of infections caused by the protozoan parasite leishmania is now extensive and has pinpointed the importance of T cell-mediated immunity. Several vaccination strategies using either killed parasites, subunit vaccines, DNA vaccines or live attenuated strains hav...

Full description

Bibliographic Details
Main Authors: Barbara Papadopoulou, Martin Olivier, Marc Ouellette
Format: Article
Language:English
Published: Hindawi Limited 1999-01-01
Series:Canadian Journal of Infectious Diseases
Online Access:http://dx.doi.org/10.1155/1999/168108
id doaj-fcfdeb1e34cb4e87875edf923c023983
record_format Article
spelling doaj-fcfdeb1e34cb4e87875edf923c0239832020-11-24T22:14:42ZengHindawi LimitedCanadian Journal of Infectious Diseases1180-23321999-01-0110Suppl C9C15C10.1155/1999/168108Recent Progress in Vaccine Development against Leishmania Species InfectionsBarbara Papadopoulou0Martin Olivier1Marc Ouellette2Centre de Recherche en Infectiologie, Université Laval, Ste-Foy, Québec, CanadaCentre de Recherche en Infectiologie, Université Laval, Ste-Foy, Québec, CanadaCentre de Recherche en Infectiologie, Université Laval, Ste-Foy, Québec, CanadaThe understanding of the immunobiology of infections caused by the protozoan parasite leishmania is now extensive and has pinpointed the importance of T cell-mediated immunity. Several vaccination strategies using either killed parasites, subunit vaccines, DNA vaccines or live attenuated strains have been used successfully with and without adjuvants to induce cellular immunity and protect against leishmania infections. The most recent progress in leishmania vaccine development is described.http://dx.doi.org/10.1155/1999/168108
collection DOAJ
language English
format Article
sources DOAJ
author Barbara Papadopoulou
Martin Olivier
Marc Ouellette
spellingShingle Barbara Papadopoulou
Martin Olivier
Marc Ouellette
Recent Progress in Vaccine Development against Leishmania Species Infections
Canadian Journal of Infectious Diseases
author_facet Barbara Papadopoulou
Martin Olivier
Marc Ouellette
author_sort Barbara Papadopoulou
title Recent Progress in Vaccine Development against Leishmania Species Infections
title_short Recent Progress in Vaccine Development against Leishmania Species Infections
title_full Recent Progress in Vaccine Development against Leishmania Species Infections
title_fullStr Recent Progress in Vaccine Development against Leishmania Species Infections
title_full_unstemmed Recent Progress in Vaccine Development against Leishmania Species Infections
title_sort recent progress in vaccine development against leishmania species infections
publisher Hindawi Limited
series Canadian Journal of Infectious Diseases
issn 1180-2332
publishDate 1999-01-01
description The understanding of the immunobiology of infections caused by the protozoan parasite leishmania is now extensive and has pinpointed the importance of T cell-mediated immunity. Several vaccination strategies using either killed parasites, subunit vaccines, DNA vaccines or live attenuated strains have been used successfully with and without adjuvants to induce cellular immunity and protect against leishmania infections. The most recent progress in leishmania vaccine development is described.
url http://dx.doi.org/10.1155/1999/168108
work_keys_str_mv AT barbarapapadopoulou recentprogressinvaccinedevelopmentagainstleishmaniaspeciesinfections
AT martinolivier recentprogressinvaccinedevelopmentagainstleishmaniaspeciesinfections
AT marcouellette recentprogressinvaccinedevelopmentagainstleishmaniaspeciesinfections
_version_ 1725797548706234368

Similar Items